NEW YORK (GenomeWeb News) — Bruker BioSciences today said fourth-quarter revenues increased 27 percent as R&D spending rose 23 percent and profit nearly doubled.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $135.6 million from $106.7 million year over year.
 
Product revenue increased 25 percent to $120.4 million; service revenue increased 45 percent to $15 million; and “other” revenue decreased 48 percent to $146,000.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more